RNA Researcher Sydney Brenner Captures 1990 Kyoto Prize For Advanced Technology

The Inamori Foundation of Japan has awarded the 1990 Kyoto Prize for Advanced Technology to Sydney Brenner, director of the Medical Research Council's Laboratory of Molecular Biology in Cambridge, England, for lifetime achievements in molecular biology research. The Kyoto Prizes, Japan's highest international awards, are given each year in three categories: advanced technology, basic sciences, and creative arts and moral sciences. The latter two were won by British primate researcher Jane Gooda

| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

In the early 1960s, Brenner made several seminal discoveries in molecular biology. He is most noted for proving the existence of messenger RNA. He proposed that a single amino acid is coded by three nucleotides--a triplet--of DNA or RNA. In addition, he demonstrated that the triplet combination of uracil, adenine, and guanine--the "nonsense codon"--signifies the end of a translation process. In more recent years, Brenner has developed the use of Caenorhabditis elegans, a nematode, as a model for investigating the genetics and nervous systems of multicellular organisms. In addition, he has successfully cloned most of the genome of C. elegans.

"The [Kyoto] award recognizes a lifetime of work, not just a discovery," says Brenner. "It's a recognition I'm very pleased to have." Although the Kyoto Prizes are meant to honor significant contributions to mankind's betterment, Brenner is not optimistic about science's immediate future. "I'm not looking forward to the next ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

  • Rebecca Andrews

    This person does not yet have a bio.

Published In

Share
May digest 2025 cover
May 2025, Issue 1

Study Confirms Safety of Genetically Modified T Cells

A long-term study of nearly 800 patients demonstrated a strong safety profile for T cells engineered with viral vectors.

View this Issue
Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Bio-Rad
How technology makes PCR instruments easier to use.

Making Real-Time PCR More Straightforward

Thermo Fisher Logo
Characterizing Immune Memory to COVID-19 Vaccination

Characterizing Immune Memory to COVID-19 Vaccination

10X Genomics
Optimize PCR assays with true linear temperature gradients

Applied Biosystems™ VeriFlex™ System: True Temperature Control for PCR Protocols

Thermo Fisher Logo

Products

The Scientist Placeholder Image

Biotium Launches New Phalloidin Conjugates with Extended F-actin Staining Stability for Greater Imaging Flexibility

Leica Microsystems Logo

Latest AI software simplifies image analysis and speeds up insights for scientists

BioSkryb Genomics Logo

BioSkryb Genomics and Tecan introduce a single-cell multiomics workflow for sequencing-ready libraries in under ten hours

iStock

Agilent BioTek Cytation C10 Confocal Imaging Reader

agilent technologies logo